|
Headline:
The entire study is based on the false premise that children's
vaccines no longer contain mercury. But, may be helpful in raising the
larger point that mercury is not the sole problem with vaccines, and it
looked at a lot of kids in a reliable state for data, California.
Conflict is high: lead author is in charge of California's immunization
program.
Actual Question This Study Asked & Answered:
Q: Has the rate of autism in California decreased since thimerosal was "removed" from vaccines?
A: No.
Did the study look at unvaccinated children?
No.
Conflict of Interest (from the study itself):
"This study was supported through the California Department of Public Health."
The lead author works in the immunization branch of the California
Department of Health, his job is to give vaccines to children.
Ability to Generalize:
The study is so fatally flawed, there is nothing to generalize about.
The study assumes that thimerosal was no longer in California’s
vaccines for kids after 2002 which is simply a false assumption (see
criticisms below for more detail). However, the study does make the
point that autism continues to grow, which calls into question the
entire vaccine schedule, rather than just one ingredient.
Post-Publication Criticism:
High, because the assumption of the study was flawed. Moreover, the
study never looked at exposure data by child, it simply generalized and
estimated.
Scoring (Out of 40 possible points):
Asked the Right Question: 1
Ability to Generalize: 0
Conflict of Interest: 0
Post-Publication Criticism: 0
Total Score: 1
Choice Excerpt from the Study:
"In the absence of exposure data for individuals or the population,
we adjusted published estimates of maximum thimerosal exposure for
infants and toddlers6 to reflect subsequent recommendations for
influenza vaccine and the fact that the third doses of DTP, DTaP, Hib,
and hepatitis B virus vaccines usually have not been recommended before 6
months of age. Based on these estimates, children aged 3 to 5 years
(Figure 3) reported to the DDS since the first quarter of 2004 are
assumed to have reduced exposure compared with children aged 3 to 5
years reported from 1995 through 2003."
Meaning: We don’t have actual thimerosal exposure data by child,
and we also did not consider if any of the mom’s received mercury-based
vaccines while pregnant, a practice that was recommended starting in
2002 (for the flu shot).
Guest Critic #1: Boyd Haley, Ph.D. Professor of Chemistry, University of Kentucky
RESPONSE TO 2008 R. SCHECHTER AND J. GRETHER PUBLICATION
'CONTINUING INCREASES IN AUTISM REPORTED TO CALIFORNIA'S DEVELOPMENTAL
SERVICES SYSTEM' WHICH ADDRESSES CALIFORNIA DEPARTMENT OF DEVELOPMENT
SERVICES DATA ON EVALUATION OF THE RELATIONSHIP BETWEEN THIMEROSAL AND
AUTISM
8 January 2008
by Boyd Haley, Professor of Chemistry, University of Kentucky, Lexington, KY
We should all consider that there are two top priorities in the
vaccine/autism issue every American should be concerned with. We need
to develop a safe vaccination program, and we need to find the cause of
autism and eliminate it if possible. I have been a strong proponent of
investigating thimerosal as the casual agent for autism spectrum
disorders based on the biological science that shows thimerosal to be
incredibly toxic, especially to infants. I know of nothing remotely as
toxic as thimerosal that numerous infants would be exposed to before 3
to 4 years of age. Below I present several comments regarding this
issue and the 2008 Schechter-Grether study that I think are relevant.
Mainly, while the Schechter-Grether study appears to be a well done
study it suffers from the fatal flaw of assuming that thimerosal was
removed to safe levels in vaccines by 2002. They also cut a fine edge
as to time when a significant drop in autism rates would be expected.
Further, no study exists that proves our vaccine schedule alone is safe,
let alone the current one that still exposes infants to thimerosal, a
concern they do not address. The alarming concern is that these authors
seem more involved at providing material saying thimerosal is safe than
they are concerned with the obvious fact, openly presented in their own
data on autism rates, which strongly indicated that increased rates of
autism started with the CDC mandated vaccine program. References to
support the comments are readily available in many recent publications.
- Autism was not a known, described illness until about 1941-3, 8 to
10 years after the introduction of thimerosal and similar organic
thiol-mercury compounds in biological mixtures used in medicine and
other areas. This argues against autism being a genetic illness.
- In 1977, 10 of 13 infants treated in a single hospital by topical
application of thimerosal for umbilical cord infections died of mercury
toxicity. This same topical was used on adolescents without obvious ill
effects which strongly supports the concept that infants are very
susceptible to thimerosal toxicity.
- The recent increase (starting about 1990) of autism spectrum
disorders correlated well with the advent of the CDC mandated vaccine
program which increased thimerosal exposures with increased
vaccinations. Due to its toxicity, thimerosal would have to be suspect
for causing autism.
- As expected by science, extensive searching for a genetic cause of
autism has not turned up a significant find that would explain the
recent increased rate in autism. The latest genetic find, at best,
might explain 0.5% of autism causation. Most agree that a genetic
predisposition is likely (like those that lead to low glutathione
levels), but that a toxic exposure is absolutely needed. Consider also,
that this increased toxic exposure would have had to occur in all 50
states at about the same time as all states have reported similar
increases in autism rates. Only something like the government
recommended vaccine program fits this need for a time dependent, uniform
exposure of a toxin throughout all the states.
- In the Schechter-Grether study it is implied or assumed that all
thimerosal containing vaccines were gone by the end of 2002 due to their
expiration dates. I don't think this is a valid assumption. I have
talked to mothers who asked to see the vaccine inserts as late as 2004
and found thimerosal present as a preservative in infant vaccines being
used in certain clinics. Also, in 2004 the influenza vaccine was
recommended by the CDC for infants 6 months of age and older. It would
appear as if a thimerosal free vaccine time-frame would be very hard to
identify, if one ever existed. I have read that the average age of
autism diagnosis is near 44 months of age. Therefore, while it does
seem reasonable to expect a decrease in autism after 4 to 5 years of
complete thimerosal removal, assuming a consistent diagnostic protocol
was used, it appears this has not been accomplished. This means the
Schechter-Grether study is likely somewhat premature in reaching the
conclusions reported in that enough time has not passed for the expected
decrease to occur and that they were quite optimistic in identifying
the dates of thimerosal reduction and underestimate exposures occurring
between 2002-4.
If, indeed, the complete removal of thimerosal from vaccines was
not followed in an appropriate time by a decrease in autism then this
would be solid proof that thimerosal was not causal for autism.
However, thimerosal has not been completely removed from vaccines and
thimerosal used at the original levels in the manufacturing of these
vaccines with a trace amounts left in the vaccines when bottled. I
don't know what level a 'trace' is since it is not a term used in
science to describe an actual amount. Some called the 12.5 micrograms
mercury in the older vaccines a a 'trace' amount. Bottom line, the
infants are still getting some level of thimerosal, a 'trace'amount that
is free and an amount of ethylmercury that is bound to the proteins
that induce the immune response.
If vaccines are causing autism and it appears this is a strong
possibility based on the California data and, if removing thimerosal
added as a preservative really does not reduce the autism rate then the
causation is much more complex.
Consider the possibilities that:
A. Autism may be caused by a thimerosal modified protein that sets
off an immune response or causes some other biological reaction that can
cascade with injurious effects. Since the vaccines are manufactured
with thimerosal present in abundance it is quite likely that any
cysteine containing proteins would be modified with ethylmercury.
Removal of most of the free thimerosal (or just not adding it) would not
decrease the level of any toxic modified protein produced during the
vaccines production that might be causal. Removing the thimerosal added
as a preservative would not decrease the amount of this ethylmercury
modified protein in those vaccines with a 'trace' thimerosal levels.
B. That autism could be caused in susceptible individuals by very low
thimerosal or ethylmercury modified protein exposures due to their
genetic susceptibility or other factors (general health, gender). In
this scenario the higher thimerosal exposures are not required and the
induction of autism is not thimerosal concentration dependent at the old
and new thimerosal vaccine levels, but just requires a significant
exposure level that is met by the vaccines containing the lower a
'trace' amounts of thimerosal and past thimerosal levels in vaccine
production processes.
Bottom line, if genetic susceptibility is involved then causation of
autism may not increase linearly with increased thimerosal exposure.
Causation may only require low thimerosal exposure or exposure to
modified proteins. It is possible that the reduction of thimerosal as
in the a 'trace' was just not enough to produce a safe vaccine.
Not all toxins work like alcohol and the old 'a dose makes the toxin'
is not always correct. As long as they are used, the mere use of 'a
trace' thimerosal in vaccines along with higher levels in the flu
vaccine will always prevent a conclusive answer to thimerosal's
involvement in autism causation. What should be studied is the "no
exposure" versus the "exposed" populations with regard to autism rates.
If indeed autism is rare among the non-vaccinated Amish
populations, as reported by Dan Olmstead, I find it an amazingly
oversight that the CDC and others responsible for infant health do not
fund a study in this area.
This study could go both ways, if the Amish have autism rates
identical with the rest of the population the argument would be over --
neither vaccines nor thimerosal would be causal for autism, and I
personally would argue in this direction. If, however, the autism rates
in the Amish are exceptionally low then vaccines would have to be
considered as a prime suspect in causation with the presence of the
highly toxic thimerosal the main suspect.
If the results in the 2008 Schechter-Grether study hold up with time,
and complete removal of thimerosal does not cause a drop in autism
rates and the autism rates in non-vaccinated populations are low then
something else in the vaccines would have to be considered the major
causation factor for autism. However, without doing the non-vaccinated
population studies there cannot be a conclusive statement either way
about either vaccines or thimerosal as being causal for autism. The
steadfast refusal of the CDC and others to support such studies being
done is part of the reason that many parents, scientists and physicians
have severe doubts about the sincerity of their efforts to resolve this
issue. This is how I think, when I review a paper submitted for
publication I always ask why an obvious experiment wasn't done. The
study of non-vaccinated populations is a very obvious experiment that
the CDC and its supporters appear to refuse to consider. This makes me
suspicious that this knowledge exists and is being suppressed because
knowledge of the rate among the non-vaccinated population would answer
many questions.
Finally, the Schechter-Grether study may be good news to the vaccine
manufacturers and those who recommended and use the mandated vaccine
program as it serves as manufactured uncertainty about the thimerosal
involvement in autism causation. However, it presents a major concern
to the parents and families of infants since it implies that our
vaccines, even with most of the free thimerosal removed, may not be safe
and that our CDC does not have a clue about what to do make them safe.
Common sense would lead most to attack finding the cause of autism
instead of trying to prove something besides thimerosal is causal. The
major question is "are our vaccines causing autism?" -- only comparing
the non-vaccinated to the vaccinated will answer this question. Common
sense would have lead to this comparison being done first and being done
10-15 years ago. In the recent past I have recommended that parents
vaccinate their children with thimerosal free vaccines as I considered
them safe. If Schechter-Grether are correct, and vaccines, but not
thimerosal, correlate with increased autism rates, then I am in error
assuming vaccines are now safer with regards to autism risk than they
were 2000.
Guest Critic #2: Deirdre Imus Environmental Center for Pediatric Oncology
Statement on California Autism Study
In reviewing a new study published in the Archives of General
Psychiatry, "Continuing Increases in Autism Reported to California's
Developmental Services System" (January 7, 2007),1 The Deirdre Imus
Environmental Center for Pediatric Oncology finds the study’s
conclusions premature and inconsistent with published clinical research.
Using epidemiological data from the California Department of
Developmental Disabilities (DDS), researchers Schechter and Grether
reviewed the trends in autism in conjunction with decreasing amounts of
thimerosal ethyl mercury exposure. The authors concluded, "The DDS data
do not support the hypothesis that exposure to thimerosal during
childhood is a primary cause of autism."
We do not believe this conclusion is supported by the methodology and
results presented in the article. The study’s authors incorrectly cite
how long mercury-containing vaccines remained in circulation in
California and failed to account for the impact of the reintroduction of
the mercury-containing influenza vaccine. The study also failed to
provide evidence that thimerosal did not cause autism in a significant
subset of children.
The American Academy of Pediatrics (AAP) and the Centers for Disease
Control and Prevention (CDC) began recommending the influenza vaccine
for infants and pregnant women in May 2002. This recommendation
reintroduced significant amounts of mercury exposure in utero and again
at 6 and 7 months of age.
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm
It should be noted that existing stocks of mercury-containing vaccines were not recalled; they remained on clinic shelves.
We also have no way of knowing precisely how much mercury remains in
children’s vaccines today. Neither the FDA nor the CDC performs any
oversight testing to validate the level of mercury currently remaining
in children’s vaccines. Vaccine manufacturers report the amount of
mercury in vaccines but we have no independent confirmation of those
amounts. We are essentially expected to trust the manufacturers
regarding mercury content in these vaccines. While "trace" amounts of
thimerosal are still incorporated in several routine childhood vaccines,
numerous studies have found very small amounts of mercury to be a
potent developmental neurotoxin capable of causing the characteristics
we see in children with autism. (Parran et al. Toxicol Sci 2005; 86:
132-140). Decades of published research have shown mercury to be
particularly toxic to the developing fetus, infants and young children.
Thimerosal is mercury and, as the AAP has noted, "Mercury in all its
forms is toxic."
The 2004 California law that would ban the use of mercury-containing
vaccines for pregnant women and children under the age of three did not
go into effect until December of 2006. The California’s DDS does not
include children under the age of three years of age in their data.
Because of the recommendation to give the mercury-containing influenza
vaccine to pregnant women and young children, in combination with other
“trace” amounts in other vaccines, it is clear that pregnant women and
infants continued to receive mercury-containing vaccines. Therefore it
is far too soon to leap to the conclusions made by the study’s authors.
The study fails to rule out that a subset of the population could
have regressed into autism after inoculations with mercury-containing
vaccines. If we are unable to exclude this possibility, and the subset
is only 5% of the children diagnosed with autism, this could still
represent thousands of children.
The authors’ reliance on strictly epidemiological data, while
acknowledging the "absence of exposure data", along with the failure to
consider the toxicological significance of thimerosal documented in
other studies, calls into question the study’s findings and the
misleading conclusions reported in the media. The tripling of
immunizations during the 1990’s, many of which contained mercury amounts
that exceeded EPA safety guidelines cannot yet be dismissed as
contributing to the increased prevalence of autism spectrum disorders in
the United States.
Thimerosal may not be the only or the primary cause of autism. We
cannot conclude that it has been eliminated as a possible contributor in
a significant number of children. We wonder why are researchers still
defending its use -- why aren't we simply removing all of it, even trace
amounts, when this is clearly technically feasible? Would it make sense
to inject trace amounts of lead into our babies?
The only valid conclusion based on the data presented is that autism
is sadly still on the rise in California, as we’ve seen across the
world. Given the continued use of thimerosal in routine childhood
vaccines along with other ongoing environmental exposures to heavy
metals, it is not possible to eliminate mercury as a contributing factor
to this epidemic rise in autism. As we still do not know what causes
the vast majority of autism cases, we should be studying all possible
environmental triggers while cautiously avoiding any potential
neurotoxin exposures.
We are in the midst of a public health crisis in need of urgent and immediate attention.
In the absence of a plausible explanation for a disorder that has
gone from 1 in 10,000 to 1 in 150 in less than 20 years, we call on the
CDC to declare autism a national emergency and for Congress to initiate
oversight hearings to investigate what has happened to a generation of
America’s children. This is an epidemic and we believe environmental
factors are clearly implicated. There is no such thing as a genetic
epidemic.
The Deirdre Imus Environmental Center for Pediatric Oncology®
continues to support the need for an independent study that will
investigate autism rates in vaccinated versus non-vaccinated populations
and a significant investment of financial resources directed
specifically towards environmental exposures and their affects on
children’s health.
|
|